Does OxyVita, a New-Generation Hemoglobin-Based Oxygen Carrier, or Oxyglobin Acutely Interfere With Coagulation Compared With Normal Saline or 6% Hetastarch? An Ex Vivo Thromboelastography Study

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 1, 2008, Pages 34-39

  Jahr, Jonathan S ^a   Weeks, David L ^a   Desai, Poonam ^a   Lim, Jennifer C ^b   Butch, Anthony W ^a   Gunther, Robert ^c   Driessen, Bernd ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

6 hetastarch; coagulation; hemoglobin based oxygen carriers; OxyVita; thromboelastogram

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN GLUTAMER 200; HETASTARCH; OXY VITA; OXYGEN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING; BLOOD; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BLOOD VOLUME; CONTROLLED STUDY; EX VIVO STUDY; FIBRIN CLOT; HEMODILUTION; HEMORRHAGIC SHOCK; HUMAN; LABORATORY TEST; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN FUNCTION; RESUSCITATION; RISK ASSESSMENT; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; BLOOD SUBSTITUTES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBINS; HETASTARCH; HUMANS; SHOCK, HEMORRHAGIC; SODIUM CHLORIDE; THROMBELASTOGRAPHY;

EID: 38749118623     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.02.016     Document Type: Article

References (22)

1. deJonge E., and Levi M. Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 29 (2001) 1261-1267
2. Strauss R.G., Pennell B.J., and Stump D.C. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 42 (2002) 27-36
3. Huraux C., Ankri A., Eyraud D., et al. Hemostatic changes in patients receiving hydroxyethyl starch: The influence of ABO blood group. Anesth Analg 92 (2001) 1396-1401
4. Royston D., and von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thromboelastography during cardiopulmonary bypass. Br J Anaesth 86 (2001) 575-578
5. ® 5000 User's Manual (2005), Haemoscope Inc, Niles, IL
6. Morgan G.E., Mikhail M.S., and Murray M.J. Fluid management and transfusion. In: Morgan G.E., Mikhail M.S., and Murray M.J. (Eds). Clinical Anesthesiology. (ed 4) (2006), McGraw-Hill, New York, NY 696
7. ®) acutely interfere with coagulation?. Anesthesiology 103 (2005) A398 (abstr)
8. HES (6% hetastarch in 0.9% sodium chloride injection) package insert (2006), Hospira Inc, Lake Forest, IL
9. Jahr J.S., Nesargi S.B., Lewis K., et al. Blood substitutes and oxygen therapeutics: An overview and current status. Am J Ther 9 (2002) 437-443
10. Bjorkholm M., Fagrell B., Przybelski R., et al. A phase I, single, blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica 90 (2005) 505-515
11. Moore E.E., Johnson J.L., Cheng A.M., et al. Insights from studies of blood substitutes in trauma. Shock 24 (2005) 197-205
12. Ruttman T., James M., and Viljoen H. Haemodilution induces a hypercoagulable state. Br J Anaesth 76 (1996) 412-414
13. Ng K., Lam C., and Chan L. In vivo effect of haemodilution with saline on coagulation: A randomized controlled trial. Br J Anaesth 88 (2002) 475-480
14. Driessen B., Jahr J.S., Lurie F., et al. Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: A dose-response study. Crit Care Med 31 (2003) 1771-1779
15. Deusch E., Gamsjager T., Kress H.G., et al. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 97 (2003) 680-683
16. Schubert A., Przybelski R.J., Eidt J.F., et al. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: A multicenter, randomized, controlled, double-blinded trial. Anesth Analg 97 (2003) 323-332
17. Driessen B., Jahr J.S., Lurie F., et al. Effects of hemoglobin-based oxygen carrier Hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolemia model. Br J Anaesth 86 (2001) 683-692
18. Kasper S.M., Walter M., Grune F., et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 83 (1996) 921-927
19. Greenburg A.G., Kim H.W., and Hemolink Study Group. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. J Am Coll Surg 198 (2004) 373-383
20. Levy J.H., Goodnough L.T., Greilich P.E., et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 124 (2002) 35-42
21. Jahr J.S., Lurie F., Xi S., et al. A novel approach to measuring circulating blood volume: Use of a hemoglobin-based oxygen carrier (HBOC) in a rabbit model. Anesth Analg 92 (2001) 609-614
22. Matheson B., Kwansa H., Bucci E., et al. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 93 (2002) 1479-1486